FEI: Two Endurance Horses Teste Positive for Human EPO
- Topics: Article, Drug Testing, Endurance, Horse Industry News, Medications
The Fédération Equestre Internationale (FEI) has announced two adverse analytical findings involving prohibited substances.
Samples taken at the CEI1* in Doha, Qatar, on April 22 from the winning horse Centurion, ridden by Abdulla Mubarak Rashed Al Khaili, of the United Arab Emirates, have returned positive for human erythropoietin (EPO, a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations).
Samples taken at the same event from the second place finisher Sur (Mabrouk), ridden by Mohd Butti Ghemran Al Qubaisi, also of the United Arab Emirates, returned positive for human EPO, as well.
A peptide hormone that is produced naturally in the body, EPO is released from the kidneys and acts on the bone marrow to stimulate red blood cell production. An increase in red blood cells improves the amount of oxygen that the blood can carry to the body’s muscles
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with
